Which lab tests are not recommended by the ACC/AHA for coronary artery atherosclerosis screening?

Updated: Apr 09, 2021
  • Author: Sandy N Shah, DO, MBA, FACC, FACP, FACOI; Chief Editor: Yasmine S Ali, MD, MSCI, FACC, FACP  more...
  • Print

In 2013, ACC/AHA Risk Assessment commented on use of newer risk markers after quantitative risk assessment. [31] The opinion of this expert committee was that quantitative risk assessment should occur first, and if a risk-based treatment decision is uncertain, assessment of family history of CVD, hs-CRP, coronary artery calcium score, or ankle-brachial index may be considered to inform treatment decision making. The committee did not recommend routine measurement of carotid intima-media thickness for risk assessment a first atherosclerotic CVD event. The committee also did not recommend use of ApoB, chronic kidney disease, albuminuria, or cardiorespiratory fitness evaluation for risk assessment for a first atherosclerotic CVD event.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!